The latest news updates from the 2024 Symposium
-
Special ‘C. Kent Osborne Symposium’ to focus on HER2, ER crosstalk
Read More: Special ‘C. Kent Osborne Symposium’ to focus on HER2, ER crosstalkIn recognition of his pioneering work on the interplay between ER and HER2 signaling, Dr. Osborne will be the special guest at this symposium bearing his name. Speakers will explore what is known about the crosstalk between these signaling pathways, how it takes place, and the latest evidence on the most effective therapies for patients…
-
Clinical Controversies: Experts debate topics in breast cancer treatment, research
Read More: Clinical Controversies: Experts debate topics in breast cancer treatment, researchIn the first of two new ‘Controversies’ sessions at SABCS 2022, Lisa Carey, MD, ScM, FASCO, will lead discussions by experts on three important topics in breast cancer clinical care.
-
Clinical Research Workshop will focus on drug development, adherence in clinical trials
Read More: Clinical Research Workshop will focus on drug development, adherence in clinical trialsAditya Bardia, MD, MPH, will moderate this year’s Clinical Research Workshop. Among the presentations, Dawn L. Hershman, MD, MS, will discuss drug adherence in clinical trials.
-
Early-Bird discount ends soon — book your housing and register today!
Read More: Early-Bird discount ends soon — book your housing and register today!SABCS offers attendees the option to participate in person in San Antonio or virtually from anywhere in the world. Special early-bird pricing is available for both in-person and virtual registrations until October 31.
-
Highlights from the Program Committee
Read More: Highlights from the Program CommitteeSABCS Program Planning Committee members Sibylle Loibl, MD, PhD, and Fabrice André, MD, PhD, talk about what they are most looking forward to at SABCS 2022.
-
In person or virtual — network and connect at #SABCS22
Read More: In person or virtual — network and connect at #SABCS22In addition to a cutting-edge scientific program, SABCS 2022 will offer attendees a variety of opportunities to engage, interact, and network with speakers, exhibitors, and one another.
-
SABCS 2022: Spotlight on Clinical Science
Read More: SABCS 2022: Spotlight on Clinical ScienceFrom the latest clinical trial results to the newest therapies finding their way to the clinic, the SABCS 2022 scientific program showcases the most important and most impactful clinical advances in breast cancer treatment.
-
Highlights from the Program Committee — The Patient Perspective
Read More: Highlights from the Program Committee — The Patient PerspectivePatient advocate and SABCS Program Planning Committee member Thelma Brown, BSc, talks about what she’s looking forward to at SABCS 2022 and why you will not want to miss this year’s meeting.
-
Final call for late-breaking abstract submissions
Read More: Final call for late-breaking abstract submissionsRegular abstract submission has closed, but there is still time to submit late-breaking abstracts for consideration. The deadline to submit a late-breaking abstract is September 30.
-
Join us in San Antonio — register today!
Read More: Join us in San Antonio — register today!While SABCS 2022 registration will once again feature a virtual option for those who can’t make it to San Antonio, there is no substitute for the in-person experience.